Back to Search
Start Over
Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib.
- Source :
-
Hematological oncology [Hematol Oncol] 2020 Oct; Vol. 38 (4), pp. 607-610. Date of Electronic Publication: 2020 Jul 23. - Publication Year :
- 2020
- Subjects :
- Adult
Aged
Aged, 80 and over
Disease-Free Survival
Female
Follow-Up Studies
Humans
Male
Middle Aged
Survival Rate
Chromosomes, Human, Pair 22 genetics
Chromosomes, Human, Pair 22 metabolism
Chromosomes, Human, Pair 9 genetics
Chromosomes, Human, Pair 9 metabolism
Fusion Proteins, bcr-abl blood
Fusion Proteins, bcr-abl genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive blood
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive mortality
Pyrimidines administration & dosage
RNA, Messenger blood
RNA, Messenger genetics
RNA, Neoplasm blood
RNA, Neoplasm genetics
Translocation, Genetic
Subjects
Details
- Language :
- English
- ISSN :
- 1099-1069
- Volume :
- 38
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Hematological oncology
- Publication Type :
- Report
- Accession number :
- 32602167
- Full Text :
- https://doi.org/10.1002/hon.2765